MedTrace Logo

The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty

NCT04304287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-03-23

No results posted yet for this study

Summary

The investigators studied the benefit of preoperative autologous blood donation in participants who undergo total hip arthroplasty. Study is made as a prospective and randomized.

Conditions

  • Transfusion
  • Hip Arthroplasty

Interventions

PROCEDURE

Preoperative autologous blood donation, 14 days before surgery

PROCEDURE

Preoperative autologous blood donation, 72 hours before surgery

PROCEDURE

Without preoperative blood donation

Sponsors & Collaborators

  • Clinical Hospital Centre Zagreb

    lead OTHER

Principal Investigators

  • Domagoj Delimar, MD · Clinical Hospital Centre Zagreb

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-16
Primary Completion
2013-06-15
Completion
2015-06-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04304287 on ClinicalTrials.gov